Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Cancer Cell Int

From Bioblast
Revision as of 14:41, 10 December 2019 by Plangger Mario (talk | contribs) (Created page with "{{Journal |Title=[https://cancerci.biomedcentral.com/ Cancer Cell International] }}")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Journals in Bioblast
Journal title and website Cancer Cell International

Publications

 ReferencePublishedView
Wang 2023 Cancer Cell IntWang Y, Wang J, Chen L, Chen Z, Wang T, Xiong S, Zhou T, Wu G, He L, Cao J, Liu M, Li H, Gu H (2023) PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis. https://doi.org/10.1186/s12935-023-03178-02023Cancer Cell Int 23:323. PMID: 38102641 Open Access
Shim 2022 Cancer Cell IntShim JK, Choi S, Yoon SJ, Choi RJ, Park J, Lee EH, Cho HJ, Lee S, Teo WY, Moon JH, Kim HS, Kim EH, Cheong JH, Chang JH, Yook JI, Kang SG. (2022) Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres. Cancer Cell Int 22:309.2022PMID:36221088 Open Access
Sharma 2021 Cancer Cell IntSharma P, Sharma V, Ahluwalia TS, Dogra N, Kumar S, Singh S (2021) Let-7a induces metabolic reprogramming in breast cancer cells via targeting mitochondrial encoded ND4. Cancer Cell Int 21:629.2021PMID: 34838007 Open Access
Gao 2019 Cancer Cell IntGao Y, Dorn P, Liu S, Deng H, Hall SRR, Peng RW, Schmid RA, Marti TM (2019) Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment. Cancer Cell Int 19:317.2019PMID: 31798346 Open Access